Alexion is a global biopharmaceutical company headquartered in New Haven, dedicated to developing innovative therapies for individuals affected by rare disorders.
The company's primary focus is on creating life-changing treatments that improve the quality of life for those living with these rare conditions.
Generated from their website's infomation